Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA4 | P22748 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.34 |
| ▸ | CA3 | P07451 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL975247 | 1.00 | HCAR2 (0.36) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7144454 | 0.84 | CYP1A2 (0.33) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7144449 | 0.84 | CYP1A2 (0.33) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7144448 | 0.84 | CYP1A2 (0.33) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL19688849 | 0.83 | GLA (0.37) | KDM4EMEN1ALDH1A1LMNAGLA | |
| SCHEMBL183861 | 0.80 | HCAR2 (0.39) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL6446355 | 0.80 | HCAR2 (0.39) | HCAR2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL10378479 | 0.77 | — | — | |
| SCHEMBL21156016 | 0.75 | ALDH1A1 (0.40) | CYP3A4MAPK1TSHRMEN1ALDH1A1 | |
| SCHEMBL3133219 | 0.74 | HCAR2 (0.34) | HCAR2HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2268614-B1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2013-05-15 | — | — | EP | claimed |
| US-8258340-B2 | Method for producing β-mercapto carboxylic acids | SHOWA DENKO K.K. (JP) | 2012-09-04 | — | — | US | claimed |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-20 | — | — | US | claimed |
| EP-2268614-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | Showa Denko K.K. (JP) | 2011-01-05 | — | — | EP | claimed |
| WO-2009113711-A1 | METHOD FOR PRODUCING -MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2009-09-17 | — | — | WO | claimed |
| US-11834404-B2 | Derivatives of sulindac can protect normal cells against oxidative damage | UNIVERSITY OF SOUTH ALABAMA (US) | 2023-12-05 | — | — | US | disclosed |
| US-20220106250-A1 | DERIVATIVES OF SULINDAC CAN PROTECT NORMAL CELLS AGAINST OXIDATIVE DAMAGE | UNIVERSITY OF SOUTH ALABAMA (US) | 2022-04-07 | — | — | US | disclosed |
| US-11186534-B2 | Derivatives of sulindac can protect normal cells against oxidative damage | UNIVERSITY OF SOUTH ALABAMA (US) | 2021-11-30 | — | — | US | disclosed |
| US-20200095184-A1 | DERIVATIVES OF SULINDAC CAN PROTECT NORMAL CELLS AGAINST OXIDATIVE DAMAGE | UNIVERSITY OF SOUTH ALABAMA (US) | 2020-03-26 | — | — | US | disclosed |
| WO-2018170410-A1 | DERIVATIVES OF SULINDAC CAN PROTECT NORMAL CELLS AGAINST OXIDATIVE DAMAGE | UNIVERSITY OF SOUTH ALABAMA (US) | 2018-09-20 | — | — | WO | disclosed |
| EP-2268614-B1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-8258340-B2 | Method for producing β-mercapto carboxylic acids | SHOWA DENKO K.K. (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-20 | — | — | US | disclosed |
| EP-2268614-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | Showa Denko K.K. (JP) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009113711-A1 | METHOD FOR PRODUCING -MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2009-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834404-B2 | Derivatives of sulindac can protect normal cells against oxidative damage | PRDX3, PRDX5, SQOR | HCAR2 1908/4885HDAC3 463/4885HDAC4 1558/4885 |
| US-20200095184-A1 | DERIVATIVES OF SULINDAC CAN PROTECT NORMAL CELLS AGAINST OXIDATIVE DAMAGE | PRDX3, PRDX5, SQOR | HCAR2 1908/4885HDAC3 463/4885HDAC4 1558/4885 |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | CBS, ALDH7A1, CBR1 | HCAR2 174/4885HDAC3 2244/4885HDAC4 3957/4885 |
| US-20220106250-A1 | DERIVATIVES OF SULINDAC CAN PROTECT NORMAL CELLS AGAINST OXIDATIVE DAMAGE | PRDX3, PRDX5, SQOR | HCAR2 1908/4885HDAC3 463/4885HDAC4 1558/4885 |
| US-11186534-B2 | Derivatives of sulindac can protect normal cells against oxidative damage | PRDX3, PRDX5, SQOR | HCAR2 1908/4885HDAC3 463/4885HDAC4 1558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.